$PLTR The FDA is turning to AI to speed up clinical trial development.
This smells like a perfect opportunity for @PalantirTech, which already has a history of partnership with the FDA.
In 2020, the FDA awarded a $44.4 million contract to Palantir to develop an enterprise data management and analytics solution to support human drug reviews.
See on the right hand side, an excerpt from a HealthCon article in 2019 that highlighted some of the other work Palantir and the FDA had collaborated on in the past.